by European Public Health Alliance | Jan 30, 2017 | Opinion
For pharmaceuticals in Europe, 2016 marked a turning point. For the first time, in a frank and comprehensive dialogue, all the problems and deficiencies of the current business model were finally brought centre stage and discussed at the highest political level. Tough...
by European Public Health Alliance | Jan 18, 2017 | Consultation Responses, Opinion
Click on the button below to read EPHA’s respose to the Public consultation on strengthening EU cooperation on Health Technology Assessment (HTA). Download the Consultation Response ‘GOOD FENCES MAKE GOOD NEIGHBORS’: The European Public Health Alliance called on...
by EPHA | Dec 8, 2016 | Opinion
Many medicines are increasingly becoming unaffordable. Many ‘new’ medicines turn out to be no more effective than those already being used. Global health needs are not driving medical research and development. Today, access to medicines has become a global...
by European Public Health Alliance | Dec 8, 2016 | Opinion
By Yannis Natsis, Policy Co-ordinator Universal Access and Affordable Medicines EPHA’s 2016 Universal Access & Affordable Medicines Forum, co-organised with the Polish Permanent Representation to the European Union, fostered genuine dialogue with key participants...
by European Public Health Alliance | Oct 6, 2016 | Statements
By Yannis Natsis @ynatsis Policy Coordinator, Universal Access & Affordable Medicines, EPHA The much-anticipated report of the UN High Level Panel on Access to Medicines, convened by Secretary-General Ban Ki-Moon, was released on September 14. The report reaffirms...
